Table 3.
Reasons for dose reduction and/or discontinuation
| n (%) | |
| Dose reduction, n (%) | 11 (44) |
| Diarrhea, n | 4 |
| Hepatotoxicity, n | 7 |
| Discontinuation, n (%) | 4 (16) |
| Diarrhea, n | 2 |
| Anorexia, n | 1 |
| Progression of IPF, n | 1 |
IPF, idiopathic pulmonary fibrosis
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.